论文信息 - B3-06: Interim safety results from TRUST, a global open-label study of erlotinib in patients with advanced non-small-cell lung cancer (NSCLC) - 字舞流文

B3-06: Interim safety results from TRUST, a global open-label study of erlotinib in patients with advanced non-small-cell lung cancer (NSCLC)

A. Ardizzoni | M. Lichinitser | U. Yilmaz | M. Gottfried | G. Cervantes | E. Razis | J. Meerbeeck | J. Skřičková | A. Grigorescu | J. Morero